Efficacy and safety of additional olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled, crossover study.

Veerisa Vimolchalao,Siwat Sakdejayont,Ploytuangporn Wongchanapai,Shama Sukprakun,Suleepon Uttamapinan,Nattaya Sintawichai,Nattaya Poovorawan,Sutima Luangdilok,Napa Parinyanitikul,Chanida Vinayanuwattikun,Virote Sriuranpong,Suebpong Tanasanvimon

Efficacy and safety of additional olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled, crossover study.

2018

Veerisa Vimolchalao
Siwat Sakdejayont
Ploytuangporn Wongchanapai
Shama Sukprakun
Suleepon Uttamapinan
Nattaya Sintawichai
Nattaya Poovorawan
Sutima Luangdilok
Napa Parinyanitikul
Chanida Vinayanuwattikun
Virote Sriuranpong
Suebpong Tanasanvimon

10019Background: Currently, the antiemetic regimen consisting of dexamethasone, palonosetron plus a NK-1 antagonist or olanzapine is recommended in prevention of chemotherapy induced nausea and vom...

Keywords:

Dexamethasone
Physical therapy
Placebo
Ondansetron
Olanzapine
Crossover study
Chemotherapy-induced nausea and vomiting
Medicine
Palonosetron
Anesthesia
Nausea

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations